Clinical Trials Logo
  1. Home
  2. Larynx
  3. NCT03162731

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Larynx Clinical Trial

Official title:
A Pilot Trial of Nivolumab and Ipilimumab in Combination With Radiotherapy in Patients With Locally Advanced Head and Neck Cancer; CA209-931

Clinical Trial Summary

This pilot clinical trial studies the side effects of nivolumab, ipilimumab and radiation therapy in treating patients with stage IVA-B head and neck cancer. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may work better in treating patients with stage IVA-B head and neck cancer.

Clinical Trial Description

PRIMARY OBJECTIVES: I. To investigate the safety of the combination of nivolumab and ipilimumab with radiation treatment for definitive management of patients with locally advanced squamous cell carcinoma of the head and neck. SECONDARY OBJECTIVES: I. To estimate the 1 year progression-free survival (PFS) in all patients treated. II. To assess the overall response rate and overall survival of patients at one year TERTIARY OBJECTIVES: I. To explore whether PDL1 expression is associated with treatment response. II. To explore whether there is a net change in the Th1/Th2 ratio (IFN-gamma, IL-4, IL10, etc) or cell subset frequencies (M2 monocytes, myeloid-derived suppressor cells, etc) within a patient's peripheral blood either at baseline or in response to treatment is associated with treatment response. III. To explore whether exosomes or other immune related serum biomarkers change after combination therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03162731
Study type Interventional
Source Thomas Jefferson University
Contact
Status Completed
Phase Early Phase 1
Start date May 11, 2017
Completion date November 16, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT05746780 - Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Active, not recruiting NCT03529422 - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Phase 2
Completed NCT02126969 - A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Phase 2
Completed NCT01263873 - Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube N/A
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Completed NCT01649973 - Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy N/A
Withdrawn NCT04168671 - CLE During Exercise Testing in Asthma N/A
Completed NCT01321892 - Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium N/A
Recruiting NCT05636410 - Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
Recruiting NCT05565430 - Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
Completed NCT03109873 - Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer Early Phase 1
Active, not recruiting NCT03737968 - Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. Phase 2
Recruiting NCT03109171 - Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea N/A
Completed NCT02761239 - Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve N/A
Recruiting NCT05145556 - Teach Intubation by Novices in Anaesthesiology N/A
Completed NCT03030781 - Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging. N/A
Completed NCT03238365 - Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Early Phase 1
Withdrawn NCT02065128 - The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome N/A
Active, not recruiting NCT03854032 - Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Phase 2
Active, not recruiting NCT03076281 - Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Phase 2